A common tumour in an uncommon region
Mohammed Riyas Ali1, Daphylla Shisha Phanbuh1, Ravi Meher1
1Department of Otorhinolaryngology, Maulana Azad Medical College and Lok Nayak Hospital, Delhi, New Delhi 110002 India.
Summary
This study details a rare case of a parotid gland lipoma, a benign soft tissue tumor. Surgical management was successfully performed for this challenging, slow-growing mass.
Area of Science:
- Head and Neck Surgery
- Surgical Oncology
- Pathology
Background:
- Lipomas are common benign soft tissue tumors, typically presenting as slow-growing, painless nodules.
- While lipomas can occur anywhere, they are rarely found in the parotid region.
- Parotid lipomas pose surgical challenges due to their proximity to the facial nerve and its branches.
Purpose of the Study:
- To report a rare case of a lipoma in the parotid gland.
- To highlight the surgical management of parotid lipomas.
- To discuss the challenges associated with resecting parotid lipomas.
Main Methods:
- Case report of a 30-year-old male patient.
- Clinical presentation of a soft mass in the right parotid gland (5.0 x 3.0 cm).
- Surgical resection of the parotid lipoma.
Main Results:
- Successful surgical removal of the parotid lipoma.
- The patient's lipoma was a benign, slow-growing soft tissue neoplasm.
- The surgical procedure addressed the challenges posed by the tumor's location.
Conclusions:
- Parotid lipomas, though rare, require careful surgical consideration.
- Surgical resection is an effective management strategy for parotid lipomas.
- Understanding the anatomical complexities is crucial for successful parotid lipoma surgery.
More Related Videos
09:33Author Spotlight: Finding New Therapeutic Targets for Malignant Peripheral Nerve Sheath Tumor Through Genome-Scale shRNA Screens
Published on: August 25, 2023
1.2K
09:21Tumorsphere Derivation and Treatment from Primary Tumor Cells Isolated from Mouse Rhabdomyosarcomas
Published on: September 13, 2019
7.2K
Related Concept Videos
02:21Cancers Originate from Somatic Mutations in a Single Cell
12.0K
Cancer arises from mutations in the critical genes that allow healthy cells to escape cell cycle regulation and acquire the ability to proliferate indefinitely. Though originating from a single mutation event in one of the originator cells, cancer progresses when the mutant cell lines continue to gain more and more mutations, and finally, become malignant. For example, chronic myelogenous leukemia (CML) develops initially as a non-lethal increase in white blood cells, which progressively...
12.0K
02:17The Tumor Microenvironment
6.7K
Every normal cell or tissue is embedded in a complex local environment called stroma, consisting of different cell types, a basal membrane, and blood vessels. As normal cells mutate and develop into cancer cells, their local environment also changes to allow cancer progression. The tumor microenvironment (TME) consists of a complex cellular matrix of stromal cells and the developing tumor. The cross-talk between cancer cells and surrounding stromal cells is critical to disrupt normal tissue...
6.7K
02:07Tumor Progression
6.4K
Tumor progression is a phenomenon where the pre-formed tumor acquires successive mutations to become clinically more aggressive and malignant. In the 1950s, Foulds first described the stepwise progression of cancer cells through successive stages.
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
Colon cancer is one of the best-documented examples of tumor progression. Early mutation in the APC gene in colon cells causes a small growth on the colon wall called a polyp. With time, this polyp grows into a benign, pre-cancerous tumor. Further...
6.4K
01:05Cancer-Critical Genes II: Tumor Suppressor Genes
7.5K
Genes usually encode proteins necessary for the proper functioning of a healthy cell. Mutations can often cause changes to the gene expression pattern, thereby altering the phenotype.
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
7.5K
02:56Treatment Resistant Cancers
3.3K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.3K
01:27Tumor Immunotherapy
555
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
555